Democritus University of Thrace (DUTH)
Μελέτη της αλληλεπίδρασης μεταξύ σπλαχνικού λιπώδους ιστού αθηροσκλήρωσης και των δεικτών φγλεγμονής χρονίως αιμοκαθαιρόμενων ασθενών
Abstract
dc:descriptionObesity per se has been recognized as a chronic disease and the deleterious effects on kidney outcome have been well proved in chronic kidney disease (CKD) patients. Paradoxically the survival in overweight or obese CKD patients undergoing maintenance hemodialysis (HD) opposed compared with the general population .Obesity has been shown to represent an important modifier of cardiovascular risk factors such as hypertension, left ventricular mass index, insulin resistance (10) as well as of cardiovascular risk per se in CKD patients (5.6).The association between under nutrition and adverse cardiovascular outcome in dialysis patients, which stands in contrast to that seen in non-ESRD(end stage renal disease) individuals, has been referred to as ‘reverse epidemiology’. Analysis of possible modifiers is considered essential in observational studies of the relationship between potential novel risk factors and clinical outcomes (10,215). Therefore, with the present study we sought to investigate the interaction of certain adipokines with levels of body mass index (BMI) and inflammatory markers for predicting all-cause mortality in a cohort of HD patients. Epidemiological evidence has shown conflicting results regarding the association between levels of adiponectin and occurrence of adverse outcomes in end-stage renal disease (ESRD) patients. Recent published data in hemodialysis (HD) patients pointed to non-linear associations between this adipokine and prognosis rendering the clinical application of the observed associations impractical. 60 patients (mean age 64±13 years, 39 men) with ESRD on maintenance HD followed up for 4.5 years represented the prospective study cohort.Measurements of adipokines, cytokines, CD40L and adhesion molecules as well as other biochemical markers were assessed and choose to present the most representative results. Associations between plasma adiponectin levels and BMI with all-cause mortality were assessed taking into account the assumption of non-linear correlations. Furthermore, the association between adiponectin, BMI and serum levels of interleukin-10 (IL-10) and interleukin-6 (IL-6) with survival was determined also cross-sectionally. The primary study end-point was death from any cause. Data are presented as percentages for categorical data, as means ± standard deviation (SD) for continuous variables that were normally distributed and as medians with interquartile range (IQR) for non-normally distributed data (adiponectin, IL-10, IL-6, triglyceride levels and duration of HD). Normal distribution was tested using the Kolmogorov- Smirnov test. Between groups comparisons were made with chi-square test, unpaired Student’s t-test and Mann-Whitney U-test as appropriate. All correlation analyses was performed my means of Spearman’s (co-efficient rho). Non-linear survival modeling showed that there was a U-shaped association of BMI with all-cause mortality whereas for plasma adiponectin levels the association was an inverse U-shaped association. Using a BMI of 24 Kg/m2 as a cut-off, an interaction effect of BMI on the association between adiponectin and mortality was observed (p=0.045). In participants with BMI ≥24 Kg/m2 each 15 μg/ml increase in plasma adiponectin levels was associated with a decreased hazard of death (HR 0.57 95%CI 0.32-0.99) in unadjusted analysis. In HD patients with BMI<24 Kg/m2 no significant association was observed between adiponectin and mortality (p=0.989). Cross-sectional analysis showed that in the sub-group of patients in whom the protective effect of adiponectin was observed (BMI≥24 Kg/m2), a positive linear association existed between adiponectin and IL-10 levels (r=0.345, p=0.027) as well as a negative association with IL-6 levels (r=-0.322, p=0.040). No association was observed in patients with BMI<24 Kg/m2 neither with IL-10 nor with IL-6. Obesity possibly modifies the effect of adiponectin on all-cause mortality in HD patients thus explaining the published conflicting results in recent literature regarding the association of plasma adiponectin levels and mortality in chronic kidney disease patients.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Τσίγαλου, Χριστίνα
- Tsigalou, Christina
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27285